Mark Waddle, MD

Disclosure:
Employment
Mayo Clinic: Resident: Employee

Presentation(s):

• TU_40_2995 - The impact of sequential or concurrent chemotherapy on toxicity and outcomes for patients treated with radiation therapy; a value of care analysis

  Tuesday, October 23
  1:00 PM – 2:30 PM

• 226 - Cost Savings of Aggressive Dose De-Escalation for Adjuvant Chemoradiation in HPV+ Oropharynx Squamous Cell Carcinoma Versus Standard of Care; Cost Analysis of a Prospective Phase II Study

  Tuesday, October 23
  5:15 PM – 5:25 PM